Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference
MINNEAPOLIS, May 21, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (VASC) today announced that the Company is scheduled to participate in the Jefferies 2012 Global Healthcare Conference being held in New York City.
James Hennen, Chief Financial Officer, will present on Monday, June 4th at 4:00pm (EDT). To hear the live audio webcast of the panel discussion, go to the investor relations page of the Company's web site www.vasc.com and click on the "Investor Conferences" icon a few minutes prior to start time to download any necessary software.
About Jefferies Group, Inc.
Jefferies Group, Inc. (NYSE:JEF), the global investment banking firm focused on serving clients for 50 years, is a leader in providing insight, expertise and execution to investors, companies and governments. The firm provides a full range of investment banking, sales, trading, research and strategy across the spectrum of equities, fixed income, foreign exchange, futures and commodities, and also select asset and wealth management strategies, in the Americas, Europe and Asia. For additional information connect to www.jefferies.com .
About Vascular Solutions, Inc.
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company's product line consists of over 60 products and services in three categories: catheter products, hemostat products and vein products. Vascular Solutions delivers its products and services to interventional cardiologists, interventional radiologists, electrophysiologists and vein specialists through its direct U.S. sales force and international independent distributor network.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2011 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of our new products, lack of sustained profitability, exposure to intellectual property claims, significant variability in quarterly results, exposure to possible product liability claims, the development of new products by others, doing business in international markets, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to
CONTACT: James Hennen, CFO Phil Nalbone, VP Vascular Solutions, Inc. (763) 656-4300Source: Vascular Solutions, Inc. 2012 GlobeNewswire, Inc.